Role of HbA1c in Predicting Adverse Pregnancy Outcomes

Sponsor
National University of Malaysia
Study ID
NCT06676254
Status
Recruiting
Apply to this trial

Conditions

  • Gestational Diabetes

Eligibility Criteria

Sex
FEMALE
Age
N/A - N/A
Healthy Volunteers
Not accepted

Study Details

This study aims to determine the reference value of HbA1c that can be used to predict adverse pregnancy outcomes. These adverse outcomes include LGA fetus, shoulder dystocia, caesarean section, pre-term birth, pre-eclampsia and fetal neonatal hypoglycaemia.

Key Dates

First listed
Nov 6, 2024
Start date
Jun 27, 2024
Status verified
Nov 2024
Primary completion
Jun 26, 2026
Completion
Jun 26, 2026

Study Design

Enrollment
195 participants (estimated)

Primary Outcome Measure

To determine the HbA1c reference value in predicting adverse pregnancy outcomes [ Time Frame: Throughout study up to 1 year ]

Central Contacts

Related Studies